Medical Waste Incinerator

“Our systems can be designed to process a few pounds of waste to thousands of pounds of waste. As medical waste increases during this pandemic it is important to limit the environmental impact and minimize additional landfill waste.” – Greg Jennings, President and CEO

BREA, Calif. (PRWEB)
April 21, 2020

Baker Furnace, a leading supplier of pollution control equipment, is excited to announce an incineration solution for infectious medical waste. As more and more people are treated for COVID-19, the amount of infectious waste produced will continue to increase. Baker Furnace manufactures medical waste incinerators that use temperatures in excess of 1,000° C to eliminate infectious pathogens and reduce waste.

According to preliminary data the COVID-19 virus survives longer outside the body than the common flu. The medical waste that hosts these pathogens will need to be treated at help centers and hospitals across the world. For example, medical personnel are using N95 masks throughout their shifts. These N95 masks may contain the COVID-19 virus and will need to be disposed of properly to eliminate the potential of infecting others. The sheer number of N95 masks and other PPE that are being used and disposed of creates a waste issue at medical facilities. If this waste is simply sterilized and taken to a landfill instead of incinerating, the environmental impact will be significant.

Medical waste incinerators provide an effective, environmentally friendly solution to the impending medical waste crisis. Baker Furnace specializes in pollution control equipment including waste incinerators that are used on pathological and infectious medical waste. These incinerators effectively destroy COVID-19 along with other virus by using a thermal oxidation process and heating the medical waste to extreme temperatures in excess of 1,000°C.

Baker Furnace’s medical waste incineration systems are designed in configurations that allow for them to be transported from site to site and only require an electric and gas connection. This provides facilities with the option to maximize their usage and waste reduction. A medical waste incinerator will not only eliminate the virus on waste but also reduce the amount of waste by up to 99%. This secondary benefit is important to consider because it minimizes the increase in landfill waste due to this pandemic and provides a cost savings to facilities on waste disposal services.

“Autoclaves can use steam to sterilize medical waste but there is no reduction of waste. Our systems can be designed to process a few pounds of waste to thousands of pounds of waste. As medical waste increases during this pandemic it is important to limit the environmental impact and minimize additional landfill waste.” – Greg Jennings, President and CEO

About Baker Furnace

Baker Furnace, Inc. has been designing, engineering, and manufacturing industrial ovens, pollution control equipment and other heating equipment since 1980. Their custom and standard equipment are used for a multitude of applications including heat treating, finishing, drying, and curing. Many of the industries they serve require specific temperature uniformity and equipment performance documentation. Their experienced engineering team can meet even the most stringent standards for their customers’ equipment. For more information visit http://www.bakerfurnace.com.

Baker Furnace is owned by Thermal Product Solutions (“TPS”), a leading American manufacturer of custom industrial ovens used for heat treating, finishing, drying, curing, manufacturing automation and process control. TPS is a global leader in thermal processing products and test solutions with brands including Blue M, Gruenberg, Tenney, Lindberg, Lunaire, MPH and Wisconsin Oven. For more information on equipment solutions from TPS visit the website at http://www.thermalproductsolutions.com.

Share article on social media or email:

Ripple Science Logo

The fact that Ripple is web-based is a game changer for us.

ANN ARBOR, Mich. (PRWEB)
April 21, 2020

Ripple Science today announced new initiatives to help clinical researchers continue their work through COVID-19. Many clinical trial teams are working remotely and have paused patient visits, forcing teams to do more of their work online. Ripple Science wants to help researchers continue their research during this uncertain time by giving research teams free access to Ripple for their first study. For those working on COVID-19 trials directly, the company is providing six months of access to Ripple free of charge.

Ripple is a web-based platform designed for clinical research teams who want a secure and streamlined way to recruit, manage, and retain patients for trials. Ripple is a purpose-built CRM and project manager which organizes clinical trial recruiting and research efforts, leading to valuable time and cost savings. Debi Gross, Community Outreach Director for Stony Brook University’s autism initiative, stated, “The fact that Ripple is web-based is a game-changer for us… The time between when participants contact us to enrolling them in a study seems a lot shorter and quicker.”

Peter Falzon, President and CEO of Ripple Science, commented, “We are committed to supporting research teams to work remotely and communicate with patients differently in response to COVID-19. Our customers have been telling us what they need and how Ripple helps, and we are responding to their needs by accelerating feature updates and expanding access.”

In the upcoming weeks, Ripple Science will release features aligned to even better support the initiatives of researchers working in this new paradigm.

About Ripple Science: Ripple Science accelerates clinical research with its secure, HIPAA-compliant suite of tools. By adapting sales and marketing automation to the process of patient recruitment, Ripple helps our customers recruit more participants faster and reduces patient loss to poor follow-up. Ripple Science’s flagship product, Ripple, is used by research investigators at more than 100 academic and research centers around the world, including Johns Hopkins University, Pennsylvania State University, University of California Los Angeles, the Brain Research Foundation Canada, University of East Anglia (UK), Cognito Therapeutics (Boston, MA) and the University of Michigan.

Share article on social media or email:

“The launch of this webinar series provides medical practices with an engaging, educational opportunity to learn how to leverage their EHR and future topics will explore additional options to help practices run more efficiently and effectively,” said Karna Morrow.

PLANO, Texas (PRWEB)
April 21, 2020

Practice EHR, a leading provider of cost-effective, cloud-based medical practice solutions, is launching a webinar series in May to educate physicians and medical practice managers on a variety of healthcare information technology topics. The free webinars are fast-paced, information-packed, and designed to help practices connect with patients and leverage platforms to maintain operational efficiency and financial success.

“The launch of this webinar series provides medical practices with an engaging, educational opportunity to learn how to leverage their EHR and future topics will explore additional options to help practices run more efficiently and effectively,” said Karna Morrow, CPC, RCC, CCS-P, implementation manager at Practice EHR. “We want the industry to understand the tools available to them, understand what questions to ask and how to better serve their patients, when everyone is trying to do more with less.”

The webinars will cover the following confirmed topics and are free to registered participants.

• 
  Selecting and Understanding Your EHR

Thursday, May 7 at 12 p.m. CT

• Connecting Practice and Patients: How to Embrace Telemedicine and the Patient Portal

Thursday, May 14 at 12 p.m. CT

• What is the Gold Standard in Revenue Cycle Management (RCM)?

Thursday, May 21 at 12 p.m. CT

Participants can learn more about and register for any of the webinars in the series at https://www.practiceehr.com/practice-ehr-webinar-events.

About Practice EHR

Practice EHR is a leading provider of cost-effective, cloud-based medical practice solutions that simplify workflows for effective patient care and financial and operational success. From electronic health records to practice management and revenue cycle management, Practice EHR provides integrated, specialty-specific solutions to more than 1,000 physicians in medical practices, long term care and home healthcare. For more information about Practice EHR, please visit http://www.PracticeEHR.com, Facebook, Twitter, or LinkedIn.

Share article on social media or email:

Real Time Hand Sanitizer is one of the highest quality 70% alcohol hand sanitizers on the market that kills 99.99% of germs.

“As a business owner, I know that nothing is more important than keeping all of your employees safe, while also giving each of your customers confidence that additional measures have been taken to make them safe,” said Tim Flatt, CEO and Co-Founder of Real Time Pain Relief.

EDMOND, Okla. (PRWEB)
April 21, 2020

Hand sanitizer during the COVID-19 pandemic has become a critical item, yet one of the hardest to find. Real Time Pain Relief has stepped up to serve the country by dramatically increasing production of its 70% alcohol hand sanitizer to 30,000 units per day. Developed over the last few years, Real Time Hand Sanitizer & Skin Conditioner has been at the forefront of the company’s main Real Time Pain Relief line. With more than 20 years of experience formulating and manufacturing topical pain relief and skin care essentials, the Real Time factory has designated two lines to solely producing hand sanitizer to be used by American businesses and organizations’ employees and customers nationwide.

As Tim Flatt, CEO and Co-Founder of Real Time Pain Relief stated, “As a business owner, I know that nothing is more important than keeping all of your employees safe, while also giving each of your customers confidence that additional measures have been taken to make them safe. We see this as a win-win as we continue to do our part to help businesses across the country stay open, while sales of the hand sanitizer should be enough to keep all of our employees on payroll during these unprecedented times,” concluded Flatt.

Real Time Hand Sanitizer is one of the highest quality 70% alcohol hand sanitizers on the market that kills 99.99% of germs. It is fragrance free and made without any parabens, artificial dyes or sodium lauryl sulfate. It is especially beneficial because it is infused with four skin conditioning ingredients – Aloe Vera, Vitamin E, Glycerin and Chamomile, which offer nourishment to the skin, which is especially important when frequent use is necessary. Most major retail stores have made the use of hand sanitizer mandatory after every customer interaction, including the handling of cash, credit cards or items touched by customers. This is likely to remain standard practice as the country reopens during the COVID-19 crisis. According to the Centers for Disease Control (CDC), hand sanitizers with 70% alcohol kill 99.99% of germs, including Human Coronavirus, common colds and flu viruses.

“Real Time Pain Relief is thrilled to be able to have the ability to substantially increase production of our high quality 70% alcohol hand sanitizer to meet the needs of consumers as well as the many essential businesses which are keeping America running during this difficult time,” said Ron Snodgrass, Co-Founder of Real Time Pain Relief.

Real Time Hand Sanitizer & Skin Conditioner 4 oz bottle with disk cap is $8.95 each, in-stock and ready to ship. It can be purchased by anyone on Real Time Pain Relief’s website here. Bulk pricing also is available for businesses, groups and organizations requiring larger quantities of hand sanitizer.

Retail customers can order Real Time Hand Sanitizer by visiting https://rtpr.com/hand-sanitizer and for wholesale customers seeking to place bulk orders between 42 and 100,000 units visit https://rtpr.com/store/hand-sanitizer-bulk-offer.

About Real Time Pain Relief

The Real Time Pain Relief community spreads across the continent with families that have chosen Real Time Pain Relief for transparent labels and effective formulas. All Real Time Pain Relief formulas contain rich infusions of nature’s ingredients and steer clear of the synthetic fillers that so commonly riddle the labels of other topical pain relievers such as parabens, SLS, artificial dyes and NSAIDs or acetaminophen. For PAIN RELIEF YOU CAN TRUST ®, choose Real Time Pain Relief. Real Time Pain Relief formulates and manufactures FDA registered OTC, pain relief products. Visit RTPR.com to learn more about Real Time Pain Relief.

Media Contact

Ria Romano, Partner

RPR Public Relations, Inc.

Tel. 786-290-6413

Share article on social media or email:

Xtalks Life Science Webinars

The complexity of preclinical studies for oncology drug development is at an all-time high with the unprecedented growth of novel immunotherapies and the continued evolution of targeted therapies.

TORONTO (PRWEB)
April 21, 2020

The live webinar takes place on Tuesday, May 5, 2020 at 10am EDT (3pm BST/UK) with featured speakers from Covance:

• 
  Maryland Franklin, PhD, Executive Director of Scientific Development, Preclinical Oncology
• Suso Platero, PhD, Global Lead, Precision Medicine and Head, Biomarker Solutions Center
• Kamal Veer Saini, MD, Senior Medical Director – Oncology

Oncology drug development is in a period of unprecedented innovation, driven by the evolution of targeted therapies and the explosion of immuno-oncology agents. With this growth, however, comes a number of scientific challenges that require a more integrated approach to the overall drug development process.

The complexity of preclinical studies for oncology drug development is at an all-time high with the unprecedented growth of novel immunotherapies and the continued evolution of targeted therapies. This has resulted in sustained use of tried and true models like human tumor xenografts and genetically modified mouse models. It has also meant the emergence of a wider variety of models such as the rebirth of syngeneic mouse models and creation and utilization of humanized mouse strategies. Even with all of this, there is no ‘one size fits all’ approach.

Biomarkers also now encompass all areas of immuno-oncology drug development, from discovery to registration, even as companion diagnostics. Predictive biomarkers are enriching immuno-oncology trials with patients more likely to respond to treatment – resulting in better outcomes and accelerated timelines. Finally, new clinical trial designs and changes in regulatory approvals have made it possible for new drugs to reach the market at unprecedented speed.

This webinar is part of a scientific series Covance is offering focused on trends, challenges and opportunities associated with current and future applications in Oncology. Learn more and register for upcoming webinars on topics such as adoptive cell therapies, biomarker technologies for the detection of cancer driver mutations, novel targeted therapies and more.

For more information or to register for this event, visit Trends in Immuno-Oncology from Preclinical Models through Biomarkers and Clinical Trial Design.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com.

For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.

Share article on social media or email:

Canada ranked #2 in global customer service study

“This type of research is more important than ever with the customer service industry facing unprecedented challenges due to Covid-19. Understanding how to make customers feel comfortable and appreciated is more important than ever,” says Andrée-Anne Chailler, VP of Operations at Intouch Insight.

OTTAWA, Canada (PRWEB)
April 21, 2020

It’s no surprise that Canada, a country known for being polite and friendly, ranks among the best for flashing those pearly whites. In the latest edition of the Smiling Report – an annual study of customer service standards – Canada is recognized as a leader in smiling, ranked 2nd only to Georgia. Intouch Insight, a leading Canadian mystery shopping and Customer Experience Management software company, was one of two groups who contributed to the Canadian data.

“We were thrilled to be included among the companies invited to participate in this global study that evaluates key customer service metrics, including whether customers receive a smile, were greeted, or received an add-on sale suggestion,” says Andrée-Anne Chailler, VP of Operations at Intouch Insight. “This type of research is more important than ever with the entire customer service industry facing unprecedented challenges due to Covid-19. Understanding how to make customers feel comfortable and appreciated while they engage with businesses in new and unique ways is now more important than ever.”

Key findings of the study:

• Georgia (99%), Canada, Moldova, Poland and Spain (94%) had the highest Smiling scores, followed by Portugal with 92%.
• Portugal attained the highest score with 98% Greeting, followed by Austria, Azerbaijan and Switzerland with 96%. Canada was the best performing country in North America with 89%.
• 2019 was the year when Add-on Sales really peaked. Add-on Sales increased from an average in 2004-2018 of 51% to 68% in 2019.

As an expert in market research focused on measuring customer service standards, conducting this kind of analysis is right up Intouch Insight’s alley. “We work with clients every day to help them understand how they can offer their customers a better experience. Leveraging our more than 40 years conducting customer service audits and surveys, it was great to be able to contribute to the Canadian data that was included in this study, not to mention seeing Canada recognized among the best worldwide,” adds Chailler.

About the study

MSPA Europe/Africa has released the 2020 Smiling Report in cooperation with Better Business World Wide and Surfmerchants, the 16th year the report has been published. The report analyzes customer service data from evaluations conducted across a whole spectrum of industries. All information is gathered by mystery shoppers from professional mystery shopping companies that are members of MSPA, the trade organization for mystery shopping professionals. The 2020 report provides a summary of almost five million answers to questions focusing on Smile, Greeting and Add-on Sales metrics from 68 countries during 2019. For more information on the 2020 Smiling Report, please visit https://www.smilingreport.com/.

About Intouch Insight

Intouch Insight (TSXV: INX) (OTCQB: INXSF) offers a complete portfolio of customer experience management (CEM) products and services that help global brands delight their customers, strengthen brand reputation and improve financial performance. Through its flagship SaaS product, LiaCXTM, Intouch helps clients collect and centralize data from multiple customer touch points, gives them actionable, real-time insights, and provides them with the tools to continuously improve customer experience. Founded in 1992, Intouch is trusted by over 300 of North America’s most-loved brands for their customer experience management, customer survey, mystery shopping, mobile forms, operational and compliance audits, and event marketing automation solutions. For more information, visit intouchinsight.com.

Share article on social media or email: